Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
NBPthis companyNovaBridge Biosciences	$0.90	-25.22×	5.02×	0×	-10.78×	-89.9%	0.0%	0.0%	0.0%	-20.0%	-40.2%	-12.4%	0.01×	2.35×	0×	8.09×	0.0%	1	7.97	2	C+
ALTAltimmune, Inc.	$2.20	-3.61×	1.41×	7,757.46×	-3.56×	-96.0%	100.0%	-230461.0%	-214861.0%	-39.2%	-35.4%	-21.2%	0.16×	0.09×	-57.76×	18.55×	0.0%	2	2.76	2	C+
ANNXAnnexon, Inc.	$4.27	-3.75×	3.68×	0×	-3.14×	-80.0%	0.0%	0.0%	0.0%	-97.7%	-91.0%	-24.0%	0.12×	0.66×	0×	5.68×	0.0%	1	-1.2	2	C
AURAAura Biosciences, Inc.	$7.24	-3.1×	2.4×	0×	-2.73×	-88.8%	0.0%	0.0%	0.0%	-77.6%	-73.1%	-25.9%	0.13×	0.4×	0×	8.15×	0.0%	2	8.97	2	C+
DMACDiaMedica Therapeutics Inc.	$9.82	-11.37×	6.66×	0×	-10.97×	-96.7%	0.0%	0.0%	0.0%	-58.4%	-61.0%	-7.8%	0×	0.47×	0×	11.81×	0.0%	1	37.36	2	C
DSGNDesign Therapeutics, Inc.	$10.55	-7.69×	2.53×	0×	-7.55×	-97.5%	0.0%	0.0%	0.0%	-32.8%	-37.1%	-10.1%	0.01×	0.22×	0×	17.14×	0.0%	1	26.54	2	C
Peer median	—	-3.75×	2.53×	0×	-3.56×	-96.0%	0.0%	0.0%	0.0%	-58.4%	-61.0%	-21.2%	0.12×	0.4×	0×	11.81×	0.0%	1	8.97	2	—